Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
San Francisco–based ZBiotics has raised $2.3 million in seed funding from the venture capital firm Oyster Ventures. ZBiotics has engineered Bacillus subtilis to make acetaldehyde dehydrogenase, an enzyme that breaks down acetaldehyde, which some studies have linked to the hangover headache. The product is sold online. ZBiotics says the funds will help it scale up the hangover treatment and develop new engineered probiotics.
This article has been sent to the following recipient: